Amgen (AMGN) Tops Q2 EPS by 26c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to Amgen (AMGN) Tops Q2 EPS by 26c, Offers Guidance

AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

August 4, 2022 4:01 PM EDT

THOUSAND OAKS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2022. Key results include:

Total revenues increased 1% to $6.6 billion in comparison to the second quarter of 2021, resulting from 3% growth in global product sales partially offset by lower Other Revenue from our COVID-19 manufacturing collaboration.Volumes grew double-digits for a number of products including Repatha® (evolocumab), Prolia® (denosumab), LUMAKRAS®/LUMYKRAS (sotorasib) and EVENITY® (romosozumab-aqqg).GAAP earnings per... More